Back to Results
First PageMeta Content
Medical equipment / Medical technology / Propel mometasone furoate implant / RTT / Sinus implant / Sinusitis / Intersect ENT / Sinus / Otorhinolaryngology / Paranasal sinuses / Frontal sinus / Balloon sinuplasty


Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In
Add to Reading List

Document Date: 2016-03-23 16:11:00


Open Document

File Size: 32,53 KB

Share Result on Facebook